Answers are grounded in this paper and cite their sources.
Background and Objectives: Minimally invasive surgery (MIS) has emerged as a less invasive alternative to medical management (MM) in intracerebral hemorrhage (ICH), but its comparative effectiveness remains uncertain. Materials and Methods: We searched PubMed, Web of Science, Scopus, and Cochrane Library for RCTs and prospective matched studies comparing MIS with MM in supratentorial spontaneous ICH. Primary outcomes were functional recovery and mortality; secondary outcomes were adverse events, rebleeding, and ICU stay. Meta-analysis was performed using RevMan 5.4 with 95% confidence intervals (CI). Results: Thirteen studies (11 RCTs, 2 cohorts; 1503 MIS, 1401 MM) were included. MIS significantly improved functional outcomes (Risk Ratio, RR 1.18, 95% CI 1.01 to 1.38), driven mainly by studies including both deep and lobar hematomas, whereas deep-only studies showed inconsistent effects. The benefit was largely attributable to stereotactic aspiration with local thrombolytics (RR 1.23, 95% CI 1.07 to 1.41), while other MIS techniques showed no significant advantage. Early intervention (<24 h) demonstrated better outcomes (RR 1.16, 95% CI 1.07–1.26). Thirty-day mortality was lower with MIS (RR 0.63, 95% CI 0.49–0.80). No significant differences were observed for ICU stay (Mean Difference, MD –0.15 days, 95% CI −1.34 to 1.05) or rebleeding (RR 1.57, 95% CI 0.84–2.97). Severe adverse events were lower in MIS (RR 0.80, 95% CI 0.71–0.89). Conclusions: MIS may reduce mortality and improve functional outcomes in supratentorial ICH, particularly using stereotactic aspiration with thrombolytics. The benefit in deep hematomas remains uncertain. Early intervention and careful patient selection are essential. Further high-quality RCTs are warranted.
No takes yet. Share an insight, caveat, or question.
Al‐Salihi et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: